vs
STANDARD BIOTOOLS INC.（LAB）与NL INDUSTRIES INC（NL）财务数据对比。点击上方公司名可切换其他公司
NL INDUSTRIES INC的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$37.7M vs $19.6M），NL INDUSTRIES INC净利率更高（-82.2% vs -177.4%，领先95.2%），NL INDUSTRIES INC同比增速更快（-1.9% vs -11.5%），NL INDUSTRIES INC自由现金流更多（$-4.7M vs $-23.1M），过去两年NL INDUSTRIES INC的营收复合增速更高（-0.4% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
NL工业公司前身为国民铅业公司，是一家铅冶炼企业，目前总部位于美国得克萨斯州休斯顿。该企业历史底蕴深厚，早在1896年5月26日道琼斯工业平均指数创立之初，NL工业就是最初纳入指数的12只成分股之一。
LAB vs NL — 直观对比
营收规模更大
NL
是对方的1.9倍
$19.6M
营收增速更快
NL
高出9.6%
-11.5%
净利率更高
NL
高出95.2%
-177.4%
自由现金流更多
NL
多$18.3M
$-23.1M
两年增速更快
NL
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $37.7M |
| 净利润 | $-34.7M | $-31.0M |
| 毛利率 | 48.5% | 32.1% |
| 营业利润率 | -168.5% | 7.6% |
| 净利率 | -177.4% | -82.2% |
| 营收同比 | -11.5% | -1.9% |
| 净利润同比 | -28.8% | -287.2% |
| 每股收益（稀释后） | $-0.09 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABNL
| Q4 25 | — | $37.7M | ||
| Q3 25 | $19.6M | $40.0M | ||
| Q2 25 | $21.8M | $40.4M | ||
| Q1 25 | $40.8M | $40.3M | ||
| Q4 24 | — | $38.4M | ||
| Q3 24 | $22.1M | $33.7M | ||
| Q2 24 | $22.5M | $35.9M | ||
| Q1 24 | $45.5M | $38.0M |
净利润LABNL
| Q4 25 | — | $-31.0M | ||
| Q3 25 | $-34.7M | $-7.9M | ||
| Q2 25 | $-33.5M | $355.0K | ||
| Q1 25 | $-26.0M | $667.0K | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | $-26.9M | $36.0M | ||
| Q2 24 | $-45.7M | $7.8M | ||
| Q1 24 | $-32.2M | $6.8M |
毛利率LABNL
| Q4 25 | — | 32.1% | ||
| Q3 25 | 48.5% | 27.6% | ||
| Q2 25 | 48.8% | 31.9% | ||
| Q1 25 | 48.4% | 30.2% | ||
| Q4 24 | — | 28.8% | ||
| Q3 24 | 54.9% | 28.1% | ||
| Q2 24 | 46.1% | 31.1% | ||
| Q1 24 | 53.1% | 25.5% |
营业利润率LABNL
| Q4 25 | — | 7.6% | ||
| Q3 25 | -168.5% | 4.6% | ||
| Q2 25 | -118.1% | 6.9% | ||
| Q1 25 | -80.8% | 7.8% | ||
| Q4 24 | — | 87.7% | ||
| Q3 24 | -120.9% | 6.0% | ||
| Q2 24 | -134.5% | 2.2% | ||
| Q1 24 | -132.2% | 3.6% |
净利率LABNL
| Q4 25 | — | -82.2% | ||
| Q3 25 | -177.4% | -19.7% | ||
| Q2 25 | -153.7% | 0.9% | ||
| Q1 25 | -63.8% | 1.7% | ||
| Q4 24 | — | 43.1% | ||
| Q3 24 | -122.0% | 107.0% | ||
| Q2 24 | -203.3% | 21.8% | ||
| Q1 24 | -70.6% | 18.0% |
每股收益（稀释后）LABNL
| Q4 25 | — | $-0.63 | ||
| Q3 25 | $-0.09 | $-0.16 | ||
| Q2 25 | $-0.09 | $0.01 | ||
| Q1 25 | $-0.07 | $0.01 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-0.07 | $0.74 | ||
| Q2 24 | $-0.12 | $0.16 | ||
| Q1 24 | $-0.27 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $110.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $358.8M |
| 总资产 | $539.6M | $464.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABNL
| Q4 25 | — | $110.6M | ||
| Q3 25 | $129.4M | $101.9M | ||
| Q2 25 | $158.6M | $111.5M | ||
| Q1 25 | $150.9M | $110.0M | ||
| Q4 24 | — | $163.2M | ||
| Q3 24 | $210.6M | $146.0M | ||
| Q2 24 | $269.8M | $179.4M | ||
| Q1 24 | $287.1M | $167.9M |
总债务LABNL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABNL
| Q4 25 | — | $358.8M | ||
| Q3 25 | $399.7M | $375.4M | ||
| Q2 25 | $424.5M | $397.6M | ||
| Q1 25 | $454.6M | $397.6M | ||
| Q4 24 | — | $396.9M | ||
| Q3 24 | $489.3M | $386.0M | ||
| Q2 24 | $510.3M | $373.1M | ||
| Q1 24 | $577.3M | $368.1M |
总资产LABNL
| Q4 25 | — | $464.2M | ||
| Q3 25 | $539.6M | $500.2M | ||
| Q2 25 | $557.0M | $523.7M | ||
| Q1 25 | $579.6M | $520.0M | ||
| Q4 24 | — | $578.3M | ||
| Q3 24 | $681.5M | $585.6M | ||
| Q2 24 | $708.7M | $580.0M | ||
| Q1 24 | $777.7M | $568.8M |
负债/权益比LABNL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-4.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-4.7M |
| 自由现金流率自由现金流/营收 | -118.1% | -12.6% |
| 资本支出强度资本支出/营收 | 4.5% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-40.1M |
8季度趋势，按日历期对齐
经营现金流LABNL
| Q4 25 | — | $-4.2M | ||
| Q3 25 | $-22.2M | $7.9M | ||
| Q2 25 | $-20.7M | $7.3M | ||
| Q1 25 | $-30.3M | $-47.5M | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | $-27.9M | $-5.7M | ||
| Q2 24 | $-39.0M | $15.5M | ||
| Q1 24 | $-62.5M | $6.7M |
自由现金流LABNL
| Q4 25 | — | $-4.7M | ||
| Q3 25 | $-23.1M | $7.0M | ||
| Q2 25 | $-22.6M | $5.9M | ||
| Q1 25 | $-35.3M | $-48.3M | ||
| Q4 24 | — | $8.7M | ||
| Q3 24 | $-30.1M | $-6.1M | ||
| Q2 24 | $-41.0M | $15.1M | ||
| Q1 24 | $-63.3M | $6.4M |
自由现金流率LABNL
| Q4 25 | — | -12.6% | ||
| Q3 25 | -118.1% | 17.4% | ||
| Q2 25 | -103.6% | 14.7% | ||
| Q1 25 | -86.6% | -119.9% | ||
| Q4 24 | — | 22.8% | ||
| Q3 24 | -136.4% | -18.3% | ||
| Q2 24 | -182.2% | 42.1% | ||
| Q1 24 | -138.9% | 17.0% |
资本支出强度LABNL
| Q4 25 | — | 1.6% | ||
| Q3 25 | 4.5% | 2.5% | ||
| Q2 25 | 8.7% | 3.3% | ||
| Q1 25 | 12.4% | 2.0% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 10.2% | 1.4% | ||
| Q2 24 | 8.6% | 1.2% | ||
| Q1 24 | 1.7% | 0.8% |
现金转化率LABNL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 20.53× | ||
| Q1 25 | — | -71.18× | ||
| Q4 24 | — | 0.54× | ||
| Q3 24 | — | -0.16× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
NL
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
